Page 88 - Sohini Das

Serum Institute, Bharat Biotech to speed up Covid-19 vaccine production

This comes after govt panel visits facilities of SII and Bharat Biotech

Panacea Biotec to make 100 mn doses of Sputnik V for global markets

More players like Serum Institute expected to join the fray to make Sputnik V

Weekend lockdown, night curfew in Maharashtra as Covid-19 cases surge

Stricter curbs from Monday; Mumbai civic authorities brace for 10,000 daily cases from next week as available beds in hospitals dry up. The city reported 9,108 cases on Sunday

Serum Institute may apply to sell Covid-19 vaccine Covishield commercially

No Covid vaccine in the world has marketing authorisation allowing sales in private market

Expert panel defers decision on Sputnik V Covid-19 vaccine, wants more data

Details of -25°C cold chain plan sought

Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL

"We expect to get the approval in the next few weeks," said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL)

Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

Covid-19 vaccination: COVAX in talks with govt to ensure speedy deliveries

SII is committed to supplying 200 million doses to the collaboration

Second Covid-19 wave: Primary health centres see a rush for vaccine

On ground, manpower concern as drive expands to rural, semi-urban areas

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge

India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development

Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority

States on overdrive to reduce vaccine wastage as Covid-19 cases rise

Experts say controlling spoilage with 10-dose vials may give vax drive a shot in the arm

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

Mumbai hospitals stare at bed crunch amid spike in Covid-19 cases

As Covid cases rise, pvt hospitals say situation could get critical in 2 weeks if momentum continues

Supply challenges for auto-disable syringe needle private hospitals

So far, the syringes were being supplied by the state government

Covaxin shows 81% efficacy in phase-3 trials, says Bharat Biotech

Firm is gearing up to produce 40 million doses a month. Two Bio-safety Level-3 facilities (which can deal with deadly and contagious viruses) have been set up, third is on the way

European Union drug regulator audits manufacturing site of Serum Institute

AstraZeneca Chief Executive (CEO) Pascal Soriot has indicated that the company may look at factories outside of the EU to meet the supply commitments.

Vaccination 2.0 gets off to a slow start in Mumbai due to tech issues

Turnout is encouraging for this round, glitch resolved after one-hour delay, say facilities

RT-PCR kit makers tweaking kits to detect new coronavirus strains

The country's apex health research body, Indian Council of Medical Research (ICMR), is receiving proposals from kit makers in this regard